Skip to main content

MoneyWorks4Me

Indoco Remedies informs about disclosure

23 Apr 2022 Evaluate

Indoco Remedies has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nippon Life India Trustee.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1905.55
Dr. Reddys Labs. 1390.10
Cipla 1417.85
Lupin 1990.50
Zydus Lifesciences 1199.50
View more..